TY  - JOUR
AU  - Navarrete, Carmen
AU  - Carrillo-Salinas, Francisco
AU  - Palomares, Belen
AU  - Mecha, Miriam
AU  - Jimenez-Jimenez, Carla
AU  - Mestre, Leyre
AU  - Feliu, Ana
AU  - Bellido, Maria L
AU  - Fiebich, Bernd L
AU  - Appendino, Giovanni
AU  - Calzado, Marco A
AU  - Guaza, Carmen
AU  - Muñoz, Eduardo
PY  - 2018
DO  - 10.1186/s12974-018-1103-y
UR  - http://hdl.handle.net/10668/12198
T2  - Journal of neuroinflammation
AB  - Multiple sclerosis (MS) is characterized by a combination of inflammatory and neurodegenerative processes variously dominant in different stages of the disease. Thus, immunosuppression is the goal standard for the inflammatory stage, and novel...
LA  - en
PB  - BioMed Central
KW  - Arginase 1
KW  - Cannabinoids
KW  - EPO
KW  - HIF-1α
KW  - Multiple sclerosis
KW  - PHDs
KW  - VEGF
KW  - Animals
KW  - Arginase
KW  - Cell hypoxia
KW  - Cell line, transformed
KW  - Cell movement
KW  - Cell polarity
KW  - Cytokines
KW  - Disease models, animal
KW  - Encephalomyelitis, autoimmune, experimental
KW  - Endothelial cells
KW  - Female
KW  - Gene expression regulation
KW  - Humans
KW  - Macrophages
KW  - Male
KW  - Mice
KW  - Mice, inbred C57BL
KW  - Microglia
KW  - Neovascularization, pathologic
KW  - Quinones
KW  - Receptor, cannabinoid, CB2
TI  - Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy.
TY  - research article
VL  - 15
ER  -